ACME Laboratories's revenue per share for the
three
months ended in Dec. 2024 was BDT41.42.
ACME Laboratories's revenue per share for the trailing twelve months (TTM) ended in Dec. 2024 was BDT158.30.
During the past 12 months, the average Revenue Per Share Growth Rate of ACME Laboratories was 14.00% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 15.40% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 13.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for ACME Laboratories's Revenue per Share or its related term are showing as below:
DHA:ACMELAB'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 11.9 Med: 12.3 Max: 15.4
Current: 15.4
During the past 9 years, ACME Laboratories's highest 3-Year average Revenue Per Share Growth Rate was 15.40% per year. The lowest was 11.90% per year. And the median was 12.30% per year.
DHA:ACMELAB's 3-Year Revenue Growth Rate is ranked better than 79.12% of 910
companies
in the Drug Manufacturers industry
Industry Median: 4.45
vs DHA:ACMELAB: 15.40
ACME Laboratories Revenue per Share Historical Data
The historical data trend for ACME Laboratories's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ACME Laboratories's Revenue per Share
For the Drug Manufacturers - Specialty & Generic subindustry, ACME Laboratories's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ACME Laboratories's PS Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ACME Laboratories's PS Ratio distribution charts can be found below:
* The bar in red indicates where ACME Laboratories's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
ACME Laboratories's Revenue Per Share for the fiscal year that ended in Jun. 2024 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT158.30
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ACME Laboratories (DHA:ACMELAB) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
ACME Laboratories Revenue per Share Related Terms
Thank you for viewing the detailed overview of ACME Laboratories's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products which includes human drugs comprising dosages form like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, sachet products; veterinary drugs comprising dosages form like bolus, liquid,injection, water-soluble powder, premix and herbal drugs comprising dosages form like liquid, capsule, tablet, cream. The products of the company are sold in domestic and international markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DHA:ACMELAB has been successfully added to your 